Cited by 26Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and TreatmentsInflammatory Bowel Disease

Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison

Open access
Montali, Lorenzo, Gragnano, Andrea, Miglioretti, Massimo, Frigerio, Alessandra, Vecchio, Luca, Gerussi, Alessio, Cristoferi, Laura, Ronca, Vincenzo +14 more·2021·Journal of Translational Autoimmunity

Abstract

BACKGROUND & AIMS: Several symptoms impair the quality of life (QoL) of patients with primary biliary cholangitis (PBC). They are reported to vary significantly in different countries. Aim of our study was to explore whether there is a geographical clustering that accounts for symptoms in PBC. METHODS: Data was analysed from four cohorts of PBC patients from the UK, Spain, Japan and Italy using the PBC-27 scale. RESULTS: Overall, 569 patients from four cohorts were identified, including 515 females (90.5%) with a mean age of 61 years. The analysis provided evidence for strict factorial invariance of the scale, a robust indicator of its validity for cross-cultural research. The mean of the fatigue domain of British patients was significantly greater than that of the Japanese (p ​< ​0.05), Italian (p ​< ​0.05), and Spanish patients (p ​< ​0.001). The mean of the cognitive domain after 54 years of age, was significantly greater in the British patients than in the Japanese (p ​< ​0.05) and Spanish patients (p ​< ​0.01). However, after 69 years of age, there were not significant differences between countries. The mean of the emotion domain after 54 years of age, was greater in the British that in the Spanish (p ​< ​0.01) and Italian patients (p ​< ​0.01). CONCLUSIONS: Differences in the four countries concerning fatigue, cognitive and emotional dysfunction were found. The association of latitude and symptoms might provide new insights into the role of sun exposure, genetics and/or cultural component into disease phenotype in PBC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jtauto.2021.100081

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pruritus, fatigue, and symptoms of associated autoimmune diseases, such as sicca syndrome, adversely affect the health-related quality of life of patients with primary biliary cholangitis.

    “However, pruritus, fatigue, and symptoms of associated auto immune diseases, such as sicca syndrome (dry eyes and mouth), adversely affect the health-related quality of life (HRQOL) of patients with primary biliary cholangitis”

    From Primary biliary cholangitis. (2024) · cites this paper as [8]

    The Introduction says that fatigue is a major determinant of reduced quality of life in PBC and lists pruritus among common symptoms. The Discussion also examines itch and dryness, and the Methods identify dryness as a quality-of-life questionnaire domain. However, our copy does not identify dryness as sicca syndrome (dry eyes and mouth) or attribute it to an associated autoimmune disease. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 24

  1. [3]Björnsson E. Kalaitzakis E. Neuhauser M. Enders F. Maetzel H. Chapman R.W. Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up Liver Int. 2010 10.1111/j.1478-3231.2009.02160.x 19922590 · DOI
  2. [4]Newton J.L. Gibson G.J. Tomlinson M. Wilton K. Jones D. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence Hepatology 2006 10.1002/hep.21230 16800007 · DOI
  3. [5]Goldblatt J. Taylor P.J.S. Lipman T. Prince M.I. Baragiotta A. Bassendine M.F. The true impact of fatigue in primary biliary cirrhosis: a population study Gastroenterology 2002 10.1053/gast.2002.32993 11984509 · DOI · Paper page
  4. [7]Al-Harthy N. Kumagi T. Coltescu C. Hirschfield G.M. The specificity of fatigue in primary biliary cirrhosis: evaluation of a large clinic practice Hepatology 2010 10.1002/hep.23683 20683955 · DOI
  5. [8]Poupon R.E. Chrétien Y. Chazouillères O. Poupon R. Chwalow J. Quality of life in patients with primary biliary cirrhosis Hepatology 2004 10.1002/hep.20276 15368455 · DOI · Paper page
  6. [9]Jones E.A. Bergasa N.V. The pathogenesis and treatment of pruritus and fatigue in patients with PBC Eur. J. Gastroenterol. Hepatol. 1999 10.1097/00042737-199906000-00007 10418933 · DOI
  7. [10]Floreani A. Marchiori M. Bonato S. Zucchetto M. Naccarato R. Chiaramonte M. Cognitive assessment in primary biliary cirrhosis: a case-control study Am. J. Gastroenterol. 1995 7847295
  8. [11]Raszeja-Wyszomirska J. Wunsch E. Krawczyk M. Rigopoulou E.I. Kostrzewa K. Norman G.L. Assessment of health related quality of life in polish patients with primary biliary cirrhosis Clin Res Hepatol Gastroenterol 2016 10.1016/j.clinre.2015.10.006 26621536 · DOI · Paper page
  9. [12]Selmi C. Gershwin M.E. Lindor K.D. Worman H.J. Gold E.B. Watnik M. Quality of life and everyday activities in patients with primary biliary cirrhosis Hepatology 2007 10.1002/hep.21953 PMC3148769 18027862 · DOI
  10. [13]Jacoby A. Rannard A. Buck D. Bhala N. Newton J.L. James O.F.W. Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis Gut 54 2005 1622 1629 10.1136/gut.2005.065862 15961522 PMC1774759 · DOI
  11. [14]Zec S. Popovic D. Matovic V. Nikolic V. Bojovic K. Jovic J. Translation and validation of the Serbian primary biliary cholangitis-40 questionnaire PloS One 2017 10.1371/journal.pone.0175697 PMC5391097 28406960 · DOI
  12. [15]Blackburn P. Freeston M. Baker C.R. Jones D.E.J. Newton J.L. The role of psychological factors in the fatigue of primary biliary cirrhosis Liver Int. 2007 10.1111/j.1478-3231.2007.01500.x 17498251 · DOI · Paper page
  13. [16]Montali L. Tanaka A. Riva P. Takahashi H. Cocchi C. Ueno Y. A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary Cirrhosis Dig. Liver Dis. 2010 10.1016/j.dld.2010.01.004 20163995 · DOI
  14. [17]He J. van de Vijver F. Bias and equivalence in cross-cultural research Online Readings Psychol Cult 2012 10.9707/2307-0919.1111 · DOI
  15. [19]Parés A. Caballería L. Rodés J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid Gastroenterology 130 2006 715 720 10.1053/j.gastro.2005.12.029 16530513 · DOI · Paper page
  16. [20]Honda A. Tanaka A. Kaneko T. Komori A. Abe M. Inao M. Bezafibrate improves GLOBE and UK-PBC scores and long-term outcomes in patients with primary biliary cholangitis Hepatology 70 2019 2035 2046 10.1002/hep.30552 30737815 · DOI
  17. [23]Jones D. Patanwala I. Newton J. Comparison of the PBC-40 and PBC-27 tools for quality of life assessment in English speaking primary biliary cirrhosis patients Gut 2011 10.1136/gut.2011.239301.516 · DOI
  18. [24]Bagozzi R.P. Yi Y. Specification, evaluation, and interpretation of structural equation models J. Acad. Market. Sci. 2012 10.1007/s11747-011-0278-x · DOI · Paper page
  19. [25]Lai K. Green S.B. The problem with having two watches: assessment of fit when RMSEA and CFI disagree Multivariate Behav. Res. 2016 10.1080/00273171.2015.1134306 27014948 · DOI · Paper page
  20. [26]Vandenberg R.J. Lance C.E. A review and synthesis of the measurement invariance literature: suggestions, practices, and recommendations for organizational research Organ. Res. Methods 2000 10.1177/109442810031002 · DOI · Paper page
  21. [27]Cheung G.W. Rensvold R.B. Evaluating goodness-of-fit indexes for testing measurement invariance Struct. Equ. Model. 2002 10.1207/S15328007SEM0902_5 · DOI · Paper page
  22. [30]Newman D.A. Limbers C.A. Varni J.W. Factorial invariance of child self-report across English and Spanish language groups in a hispanic population utilizing the pedsQLTM 4.0 generic core scales Eur. J. Psychol. Assess. 2010 10.1027/1015-5759/a000026 · DOI
  23. [31]Kalaitzakis E. Björnsson E. Fatigue and liver transplantation in patients with primary biliary cirrhosis J. Hepatol. 60 2014 1326 1328 10.1016/j.jhep.2014.01.023 24530648 · DOI
  24. [32]Björnsson E. Simren M. Olsson R. Chapman R.W. Fatigue is not a specific symptom in patients with primary biliary cirrhosis Eur. J. Gastroenterol. Hepatol. 17 2005 351 357 10.1097/00042737-200503000-00015 15716661 · DOI

Cited by

Sorted by citations

Authors
Montali, L., Gragnano, A., Miglioretti, M., Frigerio, A., Vecchio, L., Gerussi, A., Cristoferi, L., Ronca, V., D’Amato, D., O’Donnell, S. E., Mancuso, C., Lucà, M., Yagi, M., Reig, A., Jopson, L., Pilar, S., Jones, D., Pares, A., Mells, G., Tanaka, A., Carbone, M., & Invernizzi, P.
Affiliations
  • University of Milano-Bicocca (IT)
  • University of Milan (IT)
  • Teikyo University (JP)
  • Hospital Clínic de Barcelona (ES)
  • Newcastle University (GB)
  • University of Cambridge (GB)
Corresponding author
Invernizzi, Pietro
Venue
Journal of Translational Autoimmunity
Publisher
Elsevier BV
Published
2021
Volume
4
Pages
100081
ISSN
2589-9090 (ISSN-L)
OpenAlex
W3119769852
Cited by
26
References
6
Citations by year
2026: 4 · 2025: 8 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 1
FWCI
1.95
Type
journal article
Language
en
Open access
Locations
  • Journal of Translational Autoimmunity (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Institutional Repositories DataBase (IRDB) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity) (cc-by-nc-nd)
Funders
  • National Institute for Health and Care Research (NIHR200243)
  • Medical Research Council (MR/L001489/1)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
Keywords
primary biliary cirrhosis, quality of life, cross-cultural validity, measurement invariance, fatigue, cognitive impairment, emotional dysfunction, regional variation, latitude, sun exposure, disease phenotypes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review